These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1600 related articles for article (PubMed ID: 28530702)

  • 61. Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents.
    Almugadam BS; Liu Y; Chen SM; Wang CH; Shao CY; Ren BW; Tang L
    J Diabetes Res; 2020; 2020():7253978. PubMed ID: 33062716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gut microbiota transplantation from db/db mice induces diabetes-like phenotypes and alterations in Hippo signaling in pseudo germ-free mice.
    Yu F; Jiang R; Han W; Zhan G; Xu X; Jiang X; Wang L; Xiang S; Zhou Q; Liu C; Zhu B; Hua F; Yang C
    Aging (Albany NY); 2020 Nov; 12(23):24156-24167. PubMed ID: 33223509
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice.
    Yan F; Li N; Shi J; Li H; Yue Y; Jiao W; Wang N; Song Y; Huo G; Li B
    Food Funct; 2019 Sep; 10(9):5804-5815. PubMed ID: 31461095
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus.
    Liu W; Luo Z; Zhou J; Sun B
    Front Cell Infect Microbiol; 2022; 12():853771. PubMed ID: 35711668
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
    Schernthaner G; Matthews DR; Charbonnel B; Hanefeld M; Brunetti P;
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6068-76. PubMed ID: 15579760
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice.
    Lee H; Lee Y; Kim J; An J; Lee S; Kong H; Song Y; Lee CK; Kim K
    Gut Microbes; 2018 Mar; 9(2):155-165. PubMed ID: 29157127
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The co-regulation of the gut microbiome and host genes might play essential roles in metformin gastrointestinal intolerance.
    Zhang H; Lai J; Zhang L; Zhang W; Liu X; Gong Q; Tian H; Yang M; Yang T; Zhao R; Li D; Huang H; Zhao Y; Yan S; Yu M; Xiyang Y; Shi L; Yang L; Wang L; Chen W; Cao X
    Toxicol Appl Pharmacol; 2023 Dec; 481():116732. PubMed ID: 37871735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting the gastrointestinal tract to treat type 2 diabetes.
    Bauer PV; Duca FA
    J Endocrinol; 2016 Sep; 230(3):R95-R113. PubMed ID: 27496374
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study.
    Wu H; Tremaroli V; Schmidt C; Lundqvist A; Olsson LM; Krämer M; Gummesson A; Perkins R; Bergström G; Bäckhed F
    Cell Metab; 2020 Sep; 32(3):379-390.e3. PubMed ID: 32652044
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
    Díaz-Perdigones CM; Muñoz-Garach A; Álvarez-Bermúdez MD; Moreno-Indias I; Tinahones FJ
    Biomed Pharmacother; 2022 Jan; 145():112448. PubMed ID: 34844104
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.
    Mardinoglu A; Boren J; Smith U
    Cell Metab; 2016 Jan; 23(1):10-2. PubMed ID: 26771114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
    Foretz M; Guigas B; Viollet B
    Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota.
    Ahmadi S; Wang S; Nagpal R; Mainali R; Soleimanian-Zad S; Kitzman D; Yadav H
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31424444
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a
    Wei S; Brejnrod AD; Trivedi U; Mortensen MS; Johansen MY; Karstoft K; Vaag AA; Ried-Larsen M; Sørensen SJ
    Gut Microbes; 2022; 14(1):2005407. PubMed ID: 34965188
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Edgeworthia gardneri (Wall.) Meisn. water extract improves diabetes and modulates gut microbiota.
    Zhang Z; Xu H; Zhao H; Geng Y; Ren Y; Guo L; Shi J; Xu Z
    J Ethnopharmacol; 2019 Jul; 239():111854. PubMed ID: 30954614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus.
    Lv Y; Zhao X; Guo W; Gao Y; Yang S; Li Z; Wang G
    J Diabetes Res; 2018; 2018():1890978. PubMed ID: 29854817
    [TBL] [Abstract][Full Text] [Related]  

  • 80. First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat.
    Citraro R; Lembo F; De Caro C; Tallarico M; Coretti L; Iannone LF; Leo A; Palumbo D; Cuomo M; Buommino E; Nesci V; Marascio N; Iannone M; Quirino A; Russo R; Calignano A; Constanti A; Russo E; De Sarro G
    Epilepsia; 2021 Feb; 62(2):529-541. PubMed ID: 33428780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.